Core Viewpoint - The lawsuit against BellRing Brands, Inc. alleges that the company misrepresented its sales growth as being driven by consumer demand, while in reality, it was primarily due to inventory stockpiling by key customers, leading to a significant decline in share price following the revelation of competitive pressures [4][5][6]. Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased securities from November 19, 2024, to August 4, 2025, claiming that BellRing misled investors about its sales growth being attributed to "organic growth" and "strong macro tailwinds" [4]. - BellRing downplayed competitive pressures, asserting that it had a "competitive moat" in the ready-to-drink category, which was later contradicted by the actual sales performance [4]. - Following the destocking of inventory, BellRing acknowledged that competitive pressures were materially weakening demand, contradicting earlier claims [4]. Group 2: Financial Impact - On May 6, 2025, BellRing disclosed that key retailers had lowered their inventory levels, predicting a mid-single-digit headwind to third-quarter growth, resulting in a share price drop of approximately 19%, from $78.43 to $63.55 [5]. - On August 4, 2025, the company reported a disappointing sales outlook for fiscal year 2025, narrowing its net sales forecast to between $2.28 billion and $2.32 billion, which led to a further decline in share price by about 33%, from $53.64 to $36.18 [6].

Core Viewpoint - Vistagen Therapeutics, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to its Phase 3 PALISADE-3 trial of fasedienol, which did not meet its primary endpoint, leading to a significant decline in stock price [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by alleged securities fraud between April 1, 2024, and December 16, 2025 [1]. - Defendants allegedly made positive statements while concealing adverse facts about the Phase 3 PALISADE-3 trial of fasedienol, which is intended for treating social anxiety disorder [2]. - Following the announcement that the trial did not show statistically significant improvement, Vistagen's stock price plummeted from $4.36 to $0.86, a decline of over 80% [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until March 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as a top securities litigation firm in the U.S. for seven consecutive years [4].

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in CoreWeave, Inc. ("CoreWeave, Inc." or the "Company") (NASDAQ: CRWV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CoreWeave, Inc. investors who were adversely affected by alleged securities fraud between March 28, 2025 and December 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/coreweave-i ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Klarna Group plc ("Klarna Group plc" or the "Company") (NYSE: KLAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Klarna Group plc investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons who purchased or otherwise acquired Klarna securities pursuant and/or traceable to the registration statement and related prospect ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Beyond Meat, Inc. ("Beyond Meat, Inc." or the "Company") (NASDAQ: BYND) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Beyond Meat, Inc. investors who were adversely affected by alleged securities fraud between February 27, 2025 and November 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/be ...

Core Viewpoint - A class action securities lawsuit has been filed against Bath & Body Works, Inc. alleging securities fraud that affected investors between June 4, 2024, and November 9, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [2]. - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results [2]. - The complaint states that the company was unlikely to meet its previously issued financial guidance due to these issues, making positive statements about its business misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until March 13, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - The Varonis Systems, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential, leading to significant stock price declines following disappointing financial results [3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Molchanov v. Varonis Systems, Inc. and involves claims against Varonis and its executives for violations of the Securities Exchange Act of 1934 [1]. - Investors who purchased Varonis common stock between February 4, 2025, and October 28, 2025, can seek to be appointed as lead plaintiff by March 9, 2026 [1][5]. - The lawsuit alleges that Varonis misrepresented its ability to sustain revenue growth and downplayed risks associated with seasonality and macroeconomic factors [3]. Group 2: Financial Performance - On October 28, 2025, Varonis reported third-quarter results that significantly missed prior projections and subsequently lowered its full-year guidance [4]. - The CEO, Yakov Faitelson, attributed the shortfall to lower renewals in both Federal and non-Federal subscription businesses during the final weeks of the quarter [4]. - Following the announcement of these results, Varonis' stock price plummeted nearly 49% [4]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is leading the class action lawsuit and is recognized as a top law firm in securities fraud and shareholder litigation [6]. - The firm has a strong track record, having recovered over $2.5 billion for investors in 2024 alone, which is more than the combined total of the next five law firms [6].

NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against China Liberal Education Holdings Ltd. (OTCMKTS: CLEUF) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired China Liberal securities between January 22, 2025 and J ...